Showing results (221-230 of 382) with videos related to

Sort By:
Pageof 39
Vaccines|November 11, 2022
Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated PopulationHuy Quang Quach, Inna G Ovsyannikova, Diane E Grill, et al.
Clinical Immunology (Orlando, Fla.)|December 30, 2021
Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescentsMarguerite M Riggenbach, Iana H Haralambieva, Inna G Ovsyannikova, et al.
Pharmacogenetics and Genomics|November 16, 2011
Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccineInna G Ovsyannikova, Iana H Haralambieva, Robert A Vierkant, et al.
Immunogenetics|May 10, 2014
Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipientsRichard B Kennedy, Inna G Ovsyannikova, Iana H Haralambieva, et al.
The Journal of Infectious Diseases|January 19, 2005
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccinationInna G Ovsyannikova, Robert M Jacobson, Robert A Vierkant, et al.
Vaccine|May 4, 2004
Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccinationInna G Ovsyannikova, Robert M Jacobson, Robert A Vierkant, et al.
The Journal of Infectious Diseases|August 1, 2013
Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationshipInna G Ovsyannikova, Iana H Haralambieva, Richard B Kennedy, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
Polygenic Prediction of Cellular Immune Responses to Mumps VaccineBrandon J Coombes, Inna G Ovsyannikova, Daniel J Schaid, et al.
Immunogenetics|December 7, 2005
Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responsesInna G Ovsyannikova, Jenna E Ryan, Robert A Vierkant, et al.
Vaccine|June 19, 2015
Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adultsRichard B Kennedy, Pritish K Tosh, Krista M Goergen, et al.
Pageof 39